Literature DB >> 24649113

Association of Toll-like receptor 2 polymorphisms with gout.

Yan Cai1, Yi-Hua Peng2, Zhong Tang3, Xiao-Lan Guo1, Yu-Feng Qing4, Su-Hua Liang5, Hong Jiang6, Wang-Tai Dang4, Qiang Ma3, Cheng He3, Jing-Guo Zhou4.   

Abstract

Gout is the most common autoinflammatory arthritis characterized by elevated serum urate and recurrent attacks of intra-articular crystal deposition of monosodium urate (MSU) in tissues. The pathogenesis of gout has not been fully determined, although certain genetic factors are involved in the development of gout. Accumulated data suggested that MSU crystal-induced inflammation is a paradigm of innate immunity. As Toll-like receptors (TLRs) are the underlying mechanisms of the innate immune response, the present study aimed to investigate whether TLR2 polymorphisms are associated with gout. Two single-nucleotide polymorphisms (Arg677Trp and Arg753Gln, rs5743708) in TLR2 were genotyped by polymerase chain reaction-restriction fragment length polymorphism and the -196 to -174 del polymorphism was investigated using the allele-specific polymerase chain reaction in 431 individuals (215 patients with gout and 216 healthy controls). TLR2 Arg677Trp and Arg753Gln genotyping indicated that all the positive samples were of the wild-type genotype. No significant differences in genotype (χ2=1.686, P=0.430) and allele (χ2=1.430, P=0.232) frequencies of the -196 to -174 del polymorphism between the patients with gout and the control groups was observed. Our results suggested that the TLR2 Arg677Trp, Arg753Gln and the -196 to -174 del polymorphisms were not associated with susceptibility to primary gouty arthritis.

Entities:  

Keywords:  Toll-like receptor 2; arthritis; gout; polymorphism

Year:  2014        PMID: 24649113      PMCID: PMC3917755          DOI: 10.3892/br.2014.224

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  31 in total

1.  Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and susceptibility to asthma and allergic rhinitis: a case-control analysis.

Authors:  Yousri M Hussein; Hanan A Awad; Sally M Shalaby; Al-Shaymaa A Ali; Saad S Alzahrani
Journal:  Cell Immunol       Date:  2012-02-17       Impact factor: 4.868

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

3.  TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation.

Authors:  Ru Liu-Bryan; Kenneth Pritzker; Gary S Firestein; Robert Terkeltaub
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

4.  R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88.

Authors:  Yanbao Xiong; Chang Song; Greg A Snyder; Eric J Sundberg; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2012-09-19       Impact factor: 5.157

5.  Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation.

Authors:  Ru Liu-Bryan; Peter Scott; Anya Sydlaske; David M Rose; Robert Terkeltaub
Journal:  Arthritis Rheum       Date:  2005-09

6.  Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in a case-control study with bladder cancer susceptibility in a North Indian population.

Authors:  Vibha Singh; Neena Srivastava; Rakesh Kapoor; Rama Devi Mittal
Journal:  Arch Med Res       Date:  2012-11-06       Impact factor: 2.235

7.  Polymorphisms of the TLR2 and TLR4 genes are associated with risk of gastric cancer in a Brazilian population.

Authors:  Juliana Garcia de Oliveira; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2012-03-21       Impact factor: 5.742

8.  [Toll-like receptor 2 R753Q polymorphisms are associated with an increased risk of infective endocarditis].

Authors:  Juan Bustamante; Eduardo Tamayo; Santiago Flórez; Juan J Telleria; Elena Bustamante; Javier López; J Alberto San Román; F Javier Alvarez
Journal:  Rev Esp Cardiol       Date:  2011-07-23       Impact factor: 4.753

9.  Toll like receptor 2 and 4 polymorphisms in malaria endemic populations of India.

Authors:  Prerna Bali; Sabyasachi Pradhan; Divya Sharma; Tridibes Adak
Journal:  Hum Immunol       Date:  2012-11-29       Impact factor: 2.850

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  6 in total

1.  Single nucleotide polymorphism of toll-like receptor 4 (TLR4) is associated with juvenile spondyloarthritis in Croatian population.

Authors:  Marija Perica; Mandica Vidović; Lovro Lamot; Lana Tambić Bukovac; Sanja Kapitanović; Magdalena Perić; Jerko Barbić; Miroslav Harjaček
Journal:  Clin Rheumatol       Date:  2015-04-30       Impact factor: 2.980

2.  Clinical significance of the single nucleotide polymorphism TLR2 R753Q in heart transplant recipients at risk for cytomegalovirus disease.

Authors:  Martina Schneider; Teresa Matiqi; Michael Kundi; Franz J J Rieder; Martin Andreas; Robert Strassl; Andreas Zuckermann; Christof Jungbauer; Christoph Steininger
Journal:  J Clin Virol       Date:  2016-10-04       Impact factor: 3.168

3.  Bioinformatic Analysis and Cellular Assays Identify Substance P Influencing Th17/Treg Differentiation via the MyD88 Pathway as a Potential Contributor to the Progression of Asthma and Allergic Rhinitis.

Authors:  Yuemei Ma; Chang Liu; Guangpeng Xi; Yuanyuan Guan; Yao Tang; Jing Zhang; Yue Xu
Journal:  Dis Markers       Date:  2022-02-12       Impact factor: 3.434

Review 4.  Increased Risk of Cancer in relation to Gout: A Review of Three Prospective Cohort Studies with 50,358 Subjects.

Authors:  Weijie Wang; Donghua Xu; Bin Wang; Shushan Yan; Xiaochen Wang; Yin Yin; Xuehao Wang; Beicheng Sun; Xiaoyang Sun
Journal:  Mediators Inflamm       Date:  2015-10-04       Impact factor: 4.711

5.  ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study.

Authors:  Chung-Jen Chen; Chia-Chun Tseng; Jeng-Hsien Yen; Jan-Gowth Chang; Wen-Cheng Chou; Hou-Wei Chu; Shun-Jen Chang; Wei-Ting Liao
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379

6.  Isovitexin alleviates acute gouty arthritis in rats by inhibiting inflammation via the TLR4/MyD88/NF-κB pathway.

Authors:  Xiujiang Sun; Peng Li; Xiaoyi Qu; Wenguang Liu
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.